Studies characteristics: design, treatment schedules and therapy arms with available data.

NA: information not available Sbv: pentavalent antimony.#in some cases therapy was combined with oral allopurinol (300–1,200 mg/day), or interferon γ (100 µg/m2 subcutaneously) x˜: median μ: mean SD: standard deviation.¶one or more treatment arms excluded due to absence separated data.§one treatment arm (meglumine antimoniate low dose) excluded: patients data published elsewhere and another (amphotericin B) due to absence separated data.